News
ATNFW
0.0103
0.00%
0.0000
Weekly Report: what happened at ATNFW last week (0106-0110)?
Weekly Report · 2d ago
Weekly Report: what happened at ATNFW last week (1230-0103)?
Weekly Report · 01/06 11:41
Weekly Report: what happened at ATNFW last week (1223-1227)?
Weekly Report · 12/30/2024 11:34
180 LIFE SCIENCES CORP: ANNOUNCES PRICING OF $2.9 MLN REGISTERED DIRECT OFFERING
Reuters · 12/27/2024 14:04
Weekly Report: what happened at ATNFW last week (1216-1220)?
Weekly Report · 12/23/2024 11:42
180 LIFE SCIENCES CORP - BLAIR JORDAN ASSUMES CFO ROLE ON INTERIM BASIS
Reuters · 12/18/2024 21:17
Weekly Report: what happened at ATNFW last week (1209-1213)?
Weekly Report · 12/16/2024 11:43
180 LIFE SCIENCES CORP: REGAINS FULL COMPLIANCE WITH NASDAQ LISTING RULE 5605(C)(2)
Reuters · 12/12/2024 13:04
Weekly Report: what happened at ATNFW last week (1202-1206)?
Weekly Report · 12/09/2024 11:42
Weekly Report: what happened at ATNFW last week (1125-1129)?
Weekly Report · 12/02/2024 11:42
Weekly Report: what happened at ATNFW last week (1118-1122)?
Weekly Report · 11/25/2024 11:32
Weekly Report: what happened at ATNFW last week (1111-1115)?
Weekly Report · 11/18/2024 11:29
180 LIFE SCIENCES CORP FILES FOR OFFERING OF UP TO 1.9 MLN SHARES BY THE SELLING STOCKHOLDER - SEC FILING
Reuters · 11/15/2024 21:17
Weekly Report: what happened at ATNFW last week (1104-1108)?
Weekly Report · 11/11/2024 11:44
Weekly Report: what happened at ATNFW last week (1028-1101)?
Weekly Report · 11/04/2024 11:41
180 Life Sciences Corp: Current report
Press release · 10/30/2024 00:13
Weekly Report: what happened at ATNFW last week (1021-1025)?
Weekly Report · 10/28/2024 11:32
ELRAY RESOURCES ANNOUNCES STRATEGIC SALE OF CRYPTO IGAMING TECHNOLOGY
Reuters · 10/25/2024 13:00
Weekly Report: what happened at ATNFW last week (1014-1018)?
Weekly Report · 10/21/2024 11:28
BUZZ-U.S. STOCKS ON THE MOVE-Avery Dennison, Snap-On, Avadel Pharma
Reuters · 10/17/2024 18:05
More
Webull provides a variety of real-time ATNFW stock news. You can receive the latest news about 180 Life Sciences Corp through multiple platforms. This information may help you make smarter investment decisions.
About ATNFW
180 Life Sciences Corp. is a clinical-stage biotechnology company focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis. The Company is primary focused on program to treat several inflammatory disorders using anti-TNF (tumor necrosis factor). The Company has three product development platforms: Anti-TNF platform, SCAs platform and a7nAChR platform. Anti-TNF platform is focused on fibrosis and anti-tumor necrosis factor (anti-TNF). SCAs platform is focused on drugs which are synthetic cannabidiol (CBD) or cannabigerol (CBG) analogues (SCAs). a7nAChR platform is focused on alpha 7 nicotinic acetylcholine receptor (a7nAChR). It is conducting clinical trials only for certain indications under the anti-TNF platform. The Company is undertaking preclinical research and development activities for the SCA platform.